Stay updated on ALD403 in Chronic Migraine Clinical Trial
Sign up to get notified when there's something new on the ALD403 in Chronic Migraine Clinical Trial page.

Latest updates to the ALD403 in Chronic Migraine Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe site revision history now includes v3.5.0 and removes v3.4.3.SummaryDifference0.0%

- Check16 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing v3.4.2.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.2; this appears to be a backend version change with no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedThe changes are minor UI and metadata label updates, including the glossary toggle, the 'Last Update Submitted that Met QC Criteria' label, and the 'No FEAR Act Data' item along with a new 'Revision: v3.4.0' note. They do not alter core study content, eligibility criteria, outcomes, or the study timeline.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.3.4 was applied, replacing the previous v3.3.3 label, with no study content or results changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check95 days agoChange DetectedAdded a comprehensive Locations section listing study sites across US states and international locations (including New South Wales, Victoria, and Western Australia) and removed the previous per-state location headers in favor of a consolidated locations block; Revision: v3.3.3.SummaryDifference2%

Stay in the know with updates to ALD403 in Chronic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALD403 in Chronic Migraine Clinical Trial page.